Mollie Rene Deshazo, MD in Birmingham, AL - Medicare Hematology/oncology

Mollie Rene Deshazo, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Birmingham, Alabama. She went to University Of Alabama School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Hematology/oncology. She is a member of the group practice Urology Centers Of Alabama Pc and her current practice location is 619 19th Street South, Birmingham, Alabama. You can reach out to her office (for appointments etc.) via phone at (205) 934-6600.

Mollie Rene Deshazo is licensed to practice in Alabama (license number 24415) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1487603841.

Contact Information

	Mollie Rene Deshazo, MD
	619 19th Street South, Birmingham, AL 35233
	(205) 934-6600
	Not Available

Physician's Profile

Full Name	Mollie Rene Deshazo
Gender	Female
Speciality	Hematology/oncology
Experience	24 Years
Location	619 19th Street South, Birmingham, Alabama
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mollie Rene Deshazo attended and graduated from University Of Alabama School Of Medicine in 2000

NPI Data:

NPI Number: 1487603841
Provider Enumeration Date: 05/10/2006
Last Update Date: 10/20/2011

Medicare PECOS Information:

PECOS PAC ID: 8123030558
Enrollment ID: I20060628000334

Medical Identifiers

Medical identifiers for Mollie Rene Deshazo such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1487603841	NPI	-	NPPES
009936801	Medicaid	AL
009936802	Medicaid	AL
P00376923	Other	AL	RAILROAD MEDICARE
051534114	Other	AL	BCBS
051534115	Other	AL	BCBS
051534116	Other	AL	BCBS
009936803	Medicaid	AL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	24415 (Alabama)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Brookwood Baptist Medical Center	Birmingham, AL	Hospital
St Vincent's Birmingham	Birmingham, AL	Hospital
St. Vincent's East	Birmingham, AL	Hospital
Grandview Medical Center	Birmingham, AL	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Urology Centers Of Alabama Pc	0941264345	57

News Archive

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Patients with autoimmune cerebellar ataxia have better treatment responses and outcomes if they have the nonparaneoplastic form of the condition and are seropositive for neural plasma membrane protein or glutamic acid decarboxylase 65 antibodies, suggests research.

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

A University of Texas at Arlington physicist working to create a luminescent nanoparticle to use in security-related radiation detection may have instead happened upon an advance in photodynamic cancer therapy.

Statins and diabetes both increase cataract risk

Patients using cholesterol-lowering statin drugs may be at increased risk of developing age-related cataracts, according to a study - "Age-related Cataract Is Associated with Type 2 Diabetes and Statin Use", in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Agents designed to attack blood vessels that feed a growing tumor are effective against tumor growth in laboratory experiments. However, results of early clinical trials with these inhibitors have not yet exhibited the same success observed in animal models.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mollie Rene Deshazo allows following entities to bill medicare on her behalf.

Entity Name	University Of Alabama Health Services Foundation, Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261

News Archive

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Entity Name	Urology Centers Of Alabama Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1710962550 PECOS PAC ID: 0941264345 Enrollment ID: O20041116000389

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mollie Rene Deshazo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mollie Rene Deshazo, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701	Mollie Rene Deshazo, MD 619 19th Street South, Birmingham, AL 35233 Ph: (205) 934-6600

News Archive

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Internal Medicine Doctors in Birmingham, AL

Juan Mario Bernal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500
Dr. William Randolph Maddox, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411
Jodie Ann Dionne, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530
Dr. Karl Tullio Schroeder, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345
Dr. Deepti Bahl, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999
Amitkumar Mehta, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608
Shana Monika Machado, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011

Mollie Rene Deshazo, MD - Medicare Hematology/oncology in Birmingham, AL

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Medicare Reassignments

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FibroGen announces FG-3019 interim results from phase 1/2 trial against pancreatic cancer

Serologic status and autoimmune cerebellar ataxia type predict treatment response

Physicist creates luminescent nanoparticle to use in photodynamic cancer therapy

Statins and diabetes both increase cataract risk

Timing of radiation and antiangiogenic therapy impacts treatment effectiveness

Internal Medicine Doctors in Birmingham, AL